Clinical Trial Update: Autologous Whole Blood Therapy in Chronic Idiopathic Urticaria Patients. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Autologous Whole Blood Therapy for chronic idiopathic urticaria, sponsored by Cairo University, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Urticaria

Drugs mentioned

• Autologous Whole Blood Therapy

Snippet

Sponsor: Cairo University | Conditions: Chronic Idiopathic Urticaria | Phase 3 | Status: NOT_YET_RECRUITING